A Comprehensive Guide to Gold Investment CompaniesDubious Dulhans: Instagram bride dupes Dubai-based groom, escapes with Rs 50K, leaving 150 guests strandedy77777 games 。

PHILADELPHIA — Paul George had 21 points and nine assists second in his game since bruising a bone in his left knee, leading the Philadelphia 76ers to a 102-94 victory over the Orlando Magic on Friday night. KJ Martin added 20 points to help Philadelphia improve to 6-15. The 76ers have won three of four for the first time this season. Franz Wagner scored 30 points for the Magic, and Jalen Suggs has 22. Orlando dropped to 16-9. Takeaways Magic: If the Magic are going to be taken seriously in the Eastern Conference, they’ll have to improve their three-point shooting percentage. They entered the night at an NBA-worst 31.2%. 76ers: Joel Embiid could be back sooner rather than later from chronic knee swelling. He has played only four games this season Key moment After the Magic cut a 17-point lead to seven early in the fourth, Philadelphia was able to force two turnovers, with George and Martin making baskets to extend the margin to 13. Key stat Orlando shot 4 of 21 from the floor in the second quarter and 0 for 13 from three point range in the session. It turned a two-point lead into a nine-point deficit. Philadelphia 76ers' Paul George, right, tries to get past Orlando Magic's Franz Wagner during the first half of an NBA basketball game, Friday, Dec. 6, 2024, in Philadelphia. Credit: AP/Matt Slocum Up next The Magic host Phoenix on Sunday. The 76ers are at Chicago on Sundayl.

NASA Accelerates Space Exploration, Earth Science for All in 2024

WASHINGTON (AP) — The White House on Thursday announced what it called the first-ever national strategy to counter Islamophobia, detailing more than 100 steps federal officials can take to curb hate, violence, bias and discrimination against Muslims and Arab Americans. The proposal follows a similar national plan to battle antisemitism that President Joe Biden unveiled in May 2023, as fears about increasing hatred and discrimination were rising among U.S. Jews. Officials worked on the anti-Islamophobia plan for months, and its release came five weeks before Biden leaves office — meaning implementation will mostly fall to President-elect Donald Trump , if his administration chooses to do so. In a statement announcing the strategy, the Biden administration wrote that “Over the past year, this initiative has become even more important as threats against American Muslim and Arab communities have spiked.” It said that included the October 2023 slaying of 6-year-old Wadee Alfayoumi, an American Muslim boy of Palestinian descent, who was stabbed to death in Illinois. The plan details actions the Executive Branch can take, along with more than 100 other calls to action across all sectors of society. The strategy has four basic priorities: increasing awareness of hatred against Muslims and Arabs while more widely recognizing these communities' heritages; broadly improving their safety and security; appropriately accommodating Muslim and Arab religious practices by working to curb discrimination against them; and encouraging cross-community solidarity to further counter hate. Many of those state goals are similar to the ones the Biden administration laid out in its plan to reduce antisemitism — especially the emphasis on improving safety and security and building cross-community solidarity. “While individuals have sometimes been targeted because they are thought to be Muslim, it is also crucial to recognize that Arabs are routinely targeted simply for being who they are,” the announcement of the strategy states, noting that Muslims and Arab Americans have helped build out the nation since its founding. It says that new data collection and education efforts are “increasing awareness of these forms of hate as well of the proud heritages of Muslim and Arab Americans.” The plan calls for more widely disseminating successful practices of engaging Muslim and Arab Americans in the reporting of hate crimes, and that federal agencies are now more clearly spelling out that “discrimination against Muslim and Arab Americans in federally funded activities is illegal.” The White House’s plan also urges “state, local, and international counterparts, as well as the nongovernmental sector, to pursue similar initiatives that seek to build greater unity by recognizing our common humanity, affirming our shared values and history, and embracing equal justice, liberty, and security for all." Pro-Palestinian groups decrying his administration’s full-throated support of Israel in its war with Gaza , frequently disrupted Biden campaign events, as well as those of Vice President Kamala Harris after Biden abandoned his reelection bid in July. Trump, who implemented a travel ban on people from several Muslim-majority countries during his first term, won the largest majority-Muslim US city in last months elections. Yet some Arab Americans who backed Trump have begun expressing concerns about his some of his choices to fill out his Cabinet and other picks for his incoming administration. Will Weissert, The Associated PressFunday Football: This is how the Cowboys vs Bengals conversion to The Simpsons style will be done in real time

The RTX 4090’s Price Surge: Why Now? What’s Next?Jack Daugherty scores 16 as Illinois State fends off Cornell 80-77The latest deadly strike hit the urban Nuseirat refugee camp just hours after U.S. President Joe Biden’s national security adviser, Jake Sullivan, told reporters in Jerusalem that the recent ceasefire in Lebanon has helped clear the way for a potential deal to end the war in Gaza between Israel and Hamas. The Israeli military did not immediately comment on the deadly strike in Nuseirat. Israel says it is trying to eliminate Hamas, which led the attack on southern Israel in October 2023 that sparked the war in Gaza . The Israeli military says Hamas militants hide among Gaza’s civilian population. The fighting has plunged Gaza into a severe humanitarian crisis, with experts warning of famine in some of the hardest-hit parts of the territory. Israel’s offensive has killed over 44,800 Palestinians in Gaza, more than half of them women and children, according to the Gaza Health Ministry, which does not say how many were combatants. The Israeli military says it has killed over 17,000 militants, without providing evidence. The Oct. 7, 2023 attack by Hamas killed some 1,200 people, mostly civilians, and around 250 others were taken hostage. Some 100 hostages are still inside Gaza, at least a third of whom are believed to be dead. Here's the latest: DAMASCUS, Syria — Mohammad Salim Alkhateb, an official with the National Coalition of Syrian Revolution and Opposition Forces — an internationally backed group of the opposition in exile — said his group wants to see a transitional government formed via a United Nations-backed process in the wake of Bashar Assad ouster. It is not yet clear if Hayat Tahrir al-Sham, the main rebel group now in control of Syria, will pursue such a process. The insurgents have said an interim government headed by Mohammad al-Bashir, who is also the head of the “salvation government” of HTS in its former stronghold in northern Syria, will oversee the country until March but have not made clear how the transition to a new, fully empowered government would take place. “The transitional governing body should be formed in Geneva to have international legitimacy,” said Alkhateb, who is now in Damascus. “The transitional governing body, whatever its form, whether it is the ‘salvation government’ or any other, what matters is that it has international recognition.” Alkhateb said that the unexpectedly rapid fall of Damascus and departure of Assad after opposition forces launched their offensive had created confusion and a governance vacuum. A day before the insurgents pushed into Damascus, diplomats from countries including Saudi Arabia, Qatar, Turkey, Iran and Russia met in Qatar to discuss the situation in Syria. Alkhateb said that they had discussed a scenario in which the rebels would halt their advance, keeping the territory they had captured so far in the north — including Syria’s largest city, Aleppo — and the opposition and Assad’s government would go to Geneva for talks on a political settlement to the conflict. However, he noted, “there were no Syrians in that meeting.” Assad fled to Russia before the rebel forces arrived in Damascus but has not officially announced his resignation, which is “why we are living in a vacuum rather than a political transition,” Alkhateb said. He added that creating a professional army should be a priority of the transitional government. “We do not want a civilian who was trained during the revolution to carry military weapons to become the military,” he said. Israel bombed hundreds of military sites in Syria this week in a wave of airstrikes that destroyed “most of the strategic weapons stockpiles” in the country. Israeli Prime Minister Benjamin Netanyahu said the wave of airstrikes in neighboring Syria was necessary to keep the weapons from being used against Israel following the Syrian government’s stunning collapse . WASHINGTON — White House press secretary Karine Jean-Peirre says Austin Tice, an American journalist missing in Syria for 12 years, “is a top priority for this president.” During a briefing with reporters on Thursday, Jean-Pierre said of Tice, “There is no indication that he is not alive. There’s also no indication about his location or condition.” “What our goal is, is to bring him home. And so, we hope certainly that he is alive and, as we have stated many times before, we are talking through this with the Turks and we want to do everything we can to bring him home,” she said. BEIRUT — Amnesty International said Thursday that four Israeli airstrikes between September and October that killed at least 49 civilians in Lebanon “must be investigated as war crimes.” The rights organization said in a new report that the four strikes targeted homes in the Bekaa Valley, northern and eastern Lebanon, and municipal offices in the south. “These four attacks are emblematic of Israel’s shocking disregard for civilian lives in Lebanon and their willingness to flout international law,” said Amnesty International’s Erika Guevara Rosas, Senior Director for Research, Advocacy, Policy and Campaigns. The rights group said this report was part of its ongoing investigation into violations of the laws of war in Lebanon. Amnesty International investigated four Israeli airstrikes, including one on Sept. 29 in al-Ain that killed all nine members of the same family. On Oct. 21, a strike in Baalbek city in eastern Lebanon killed six members of the same family. Another on Oct. 14 in the village of Aitou in northern Lebanon killed 23 displaced people, including a 5-month-old baby. A fragment from the attack site in Aitou was identified by an Amnesty weapons expert as likely part of a Mk-80 series aerial bomb, weighing at least 500 pounds. These munitions are primarily supplied to Israel by the United States, Amnesty said. The fourth strike Amnesty investigated was the strike that hit the municipal headquarters in Nabatiyeh, southern Lebanon, on Oct. 16, killing 11 civilians including the mayor. “The air strike took place without warning, just as the municipality’s crisis unit was meeting to coordinate deliveries of aid, including food, water and medicine, to residents and internally displaced people who had fled bombardment in other parts of southern Lebanon,” Amnesty said. The rights group said it interviewed survivors and witnesses, examined evidence, and found no military targets near the sites of the four strikes. The Israeli military gave no warnings and did not respond to Amnesty’s inquiries, the group said. DEIR AL-BALAH, Gaza Strip — An Israeli airstrike hit the central Gaza Strip on Thursday, killing at least 25 Palestinians and wounding dozens more, Palestinian medics said, just hours after President Joe Biden’s national security adviser raised hopes about a ceasefire deal to end the war in Gaza. Photos from the scene of the blast that circulated on social media showed a completely collapsed building with people walking through its mangled and charred remains, smoke rising from piles of belongings strewn over the rubble. Officials at two hospitals in the Gaza Strip, al-Awda Hospital in the north and al-Aqsa Hospital in central Gaza, reported they received a combined total of 25 bodies from an Israeli strike on a multistory residential building in the urban Nuseirat refugee camp. Palestinian medics also reported that over 40 people, most of them children, were receiving treatment at the two hospitals. The al-Aqsa Hospital said that the Israeli attack also damaged several nearby houses in Nuseirat. There was no immediate comment from the Israeli military on the deadly strike. Israel is trying to eliminate Hamas, which led the attack on southern Israel in October 2023 that sparked the war in Gaza . The Israeli military says Hamas militants hide among Gaza’s civilian population. Israel’s war against Hamas has killed over 44,800 Palestinians in Gaza, more than half of them women and children, according to the Gaza Health Ministry, which does not say how many were combatants. The Israeli military says it has killed over 17,000 militants, without providing evidence. The fighting has plunged Gaza into a severe humanitarian crisis, with experts warning of famine. Israel says it allows enough aid to enter and blames U.N. agencies for not distributing it. The U.N. says Israeli restrictions, and the breakdown of law and order after Israel repeatedly targeted the Hamas-run police force, make it extremely difficult to operate in the territory. UNITED NATIONS – The U.N. food agency is trying to deal with massive needs in Syria not only from escalating war-related food insecurity and an upsurge in displaced people fleeing Lebanon but also the dramatically new environment following the ouster of Bashar Assad, a senior U.N. official says. “It’s a triple crisis and the needs are going to be massive,” said Carl Skau, deputy executive director of the World Food Program, in an interview with The Associated Press late Wednesday. The WFP estimated that 3 million people in Syria were “acutely food insecure” and very hungry. However, that estimate was made before the Israel-Hezbollah war in Lebanon pushed many Syrian refugees back to their home country, plus the instability caused by the overthrow of Assad. Due to funding cuts, the WFP had been targeting only 2 million of those people, he said. Because WFP has been working in Syria during the 13-year civil war, he said, it has pre-positioned food in the country. It has 500 staff in seven offices nationwide and has operated across conflict lines, across borders, and with all different parties, he said. Skau said Hayat Tahrir al-Sham, the main rebel group now in control of Syria, has promised to provide security for WFP warehouses. Humanitarian aid supplies had been looted at U.N. warehouses in the disorder after Assad fell. “We’re not really up and running in Damascus because of the continued kind of uncertainty there,” he said. WFP initially thought of relocating non-essential staff but the situation in Aleppo, Syria’s largest city, has been “quite calm and orderly," he said. In the short term, Skau said, “what we’re seeing is that markets are disrupted, the value of the currency dropped dramatically, food prices are going up, transport lines don’t work,” and it’s unclear who will stamp required papers for imports and exports. This means that a bigger humanitarian response is needed initially, he said, but in the next phase, the U,N. will be looking at contributing to Syria’s recovery, and ultimately the country will need reconstruction. Skau said he expects a new funding appeal for Syria and urged donors to be generous. JERUSALEM — President Joe Biden’s national security adviser, Jake Sullivan, told reporters in Jerusalem on Thursday that Israel’s ceasefire in Lebanon has helped clear the way for another deal to end the war in Gaza. He plans to travel next to Qatar and Egypt — key mediators in the ceasefire talks — as the Biden administration makes a final push on negotiations before Donald Trump is inaugurated. Sullivan said “Hamas’ posture at the negotiating table did adapt” after Israel decimated the leadership of its ally Hezbollah in Lebanon and reached a ceasefire there. “We believe it puts us in a position to close this negotiation,” he said. Sullivan dismissed speculation that Israeli Prime Minister Benjamin Netanyahu was waiting for Trump to take office to finalize a deal. He the U.S. believes there are three American hostages still alive in Gaza, but it’s hard to know for sure. He also said “the balance of power in the Middle East has changed significantly” since Hamas’ Oct. 7 attack on Israel, especially with the overthrow of former Syrian President Bashar Assad, a key ally of Hezbollah and Iran. “We are now faced with a dramatically reshaped Middle East in which Israel is stronger, Iran is weaker, its proxies decimated, and a ceasefire that is new and will be lasting in Lebanon that ensures Israel’s security over the long term,” he said. KHIAM, Lebanon — An Israeli strike killed at least one person Thursday in the Lebanese border town of Khiam, the Health Ministry said, less than a day after Israeli troops handed the hilltop village back to the Lebanese army in coordination with U.N. peacekeepers, Khiam is the first Lebanese town Israel has pull out of since a ceasefire between Israel and Hezbollah militants began two weeks ago, and marks an important test of the fragile truce . Lebanon's Health Ministry and state news agency did not provide details on who was killed, and did not report airstrikes elsewhere on Thursday. The Israeli military said the airstrike in Khiam targeted Hezbollah fighters. Lebanese troops deployed in the northern section of the town on Thursday morning and were coordinating with U.N. peacekeepers to finalize Israel’s withdrawal before fully entering into other neighborhoods. An Associated Press reporter who visited Khiam on Thursday observed widespread destruction, with most houses reduced to rubble. Entire neighborhoods were flattened, with collapsed walls and debris scattered across the streets. Lebanon’s caretaker prime minister, Najib Mikati, sharply criticized Israel for striking the town less than 24 hours after the Lebanese army returned, saying it was “a violation of the pledges made by the parties that sponsored the ceasefire agreement, who must act to curb Israeli aggression.” The truce was brokered by the U.S. and France. Israel has previously said the ceasefire deal allows it to use military force against perceived violations. Near-daily attacks by Israel during the ceasefire, mostly in southern Lebanon, have killed at least 29 people and wounded 27 others. Khiam, which sits on a ridge less than 3 miles (5 kilometers) from the border with Israel, saw some of the most intense fighting during the war. The Lebanese army was clearing debris and reopening roads in the northern section of the town. Civilian access to other areas remained challenging as the army clears roads and works alongside the U.N. peacekeepers to ensure the area is free of unexploded ordnance. AQABA, Jordan -- U.S. Secretary of State Antony Blinken is urging the many players in Syria to avoid taking any steps that could lead to further violence. Blinken spoke to reporters in Jordan on Thursday shortly after meeting King Abdullah II as he opened a trip in the region to discuss Syria's future after former President Bashar Assad's ouster. Blinken will next visit Turkey, a NATO ally and a main backer of Syrian rebel groups. Blinken called this “a time of both real promise but also peril for Syria and for its neighbors.” He said he was focused on coordinating efforts in the region “to support the Syrian people as they transition away from Assad’s brutal dictatorship” and establish a government that isn’t dominated by one religion or ethnic group or outside power. Blinken was asked about Israel’s incursion into a buffer zone that had been demilitarized for the past half century. Israeli Prime Minister Benjamin Netanyahu says the move is temporary and defensive, but also indicated Israel will remain in the area for a long time. Blinken declined to say whether the U.S. supports the move, but said the U.S. would be speaking to Israel and other partners in the region. “I think, across the board, when it comes to any actors who have real interests in Syria, it’s also really important at this time that, we all try to make sure that we’re not sparking any additional conflicts,” he said. ANKARA, Turkey — Turkey’s intelligence chief, Ibrahim Kalin, arrived in Damascus on Thursday, according to Turkish media reports. Kalin was seen arriving at the Umayyad Mosque to pray, surrounded by a large crowd, according to video shown on Turkish television. The visit is highly symbolic. Turkish officials, who supported the opposition against Syria’s government, had predicted at the start of the civil war in 2011 that President Bashar Assad’s government would fall, allowing them to pray at the Umayyad Mosque. JERUSALEM — Paraguay reopened its embassy in Jerusalem Thursday, becoming one of a small handful of nations to recognize the city as Israel’s capital and marking a diplomatic victory for Prime Minister Benjamin Netanyahu. Israel’s international isolation has increased as the war in Gaza drags on, and Paraguay was the first country to move its embassy to Jerusalem since the Oct. 7, 2023 Hamas attack that kickstarted the war. The United States, Honduras, Guatemala, Kosovo, and Papua New Guinea are among the few countries with Jerusalem embassies. Israel annexed east Jerusalem in 1967 but it wasn’t recognized by the international community, and most countries run their embassies out of Tel Aviv. Spirits were high at the ceremony marking the embassy’s inauguration Thursday, with Netanyahu and Israel’s Foreign Minister Gideon Saar lavishing praise on Paraguayan President Santiago Pena. “My good friend Santiago,” said Netanyahu, addressing Pena. “We’re a small nation. You’re a small nation. We suffered horrible things but we overcame the odds of history...we can win and we are winning.” Paraguay had an embassy in Jerusalem in 2018, under Former President Horacio Cartes. That embassy was moved back to Tel Aviv by Cartes’ successor, Mario Abdo Benitez, prompting Israel to close its embassy in Asuncion. Saar said Israel and Paraguay shared a “friendship based not only on interests but also values and principles.” He and the Paraguayan foreign minister, Rubén Ramírez Lezcano, signed a series of bilateral agreements and Saar said he would soon visit Asunción with a delegation from the Israeli private sector. “Israel is going to win and the countries we are standing next to Israel, we are going to win," Pena said. AQABA, Jordan — U.S. Secretary of State Antony Blinken is renewing calls for Syria’s new leadership to respect women and minority rights, prevent extremists from gaining new footholds in the country and keeping suspected chemical weapons stocks secure as he makes his first visit to the Mideast since the weekend ouster of Syrian President Bashar Assad . Making his 12th trip to the Middle East since the Israel-Hamas war erupted lasted year but amid fresh concerns about security following the upheaval in Syria, Blinken emphasized Thursday to Jordan’s King Abdullah II U.S. “support for an inclusive transition that can lead to an accountable and representative Syrian government chosen by the Syrian people,” the State Department said. Blinken also repeated the importance the outgoing Biden administration puts on respect for human rights and international law, the protection of civilians and stopping terrorist groups from reconstituting. Blinken met with the monarch and Jordanian Foreign Minister Ayman Safadi in Aqaba before traveling to Turkey for talks with Turkish officials on the situation in Syria and the urgency of securing a long-elusive deal to release hostages and end the fighting in Gaza that has devastated the Palestinian territory since October 2023. Abdullah told Blinken that “the first step to reach comprehensive regional calm is to end the Israeli war on Gaza." GENEVA — The U.N. envoy for Syria is calling on authorities to save evidence from detention centers that were a hub of “unimaginable barbarity” that Syrians have faced for many years and cooperate with international investigators looking into such crimes. Geir Pederson referred to new images from the notorious Saydnaya military prison north of the capital, Damascus, after President Bashar Assad fled Syria as armed groups stormed in to overthrow his government over the weekend. “The images from Saydnaya and other detention facilities starkly underscore the unimaginable barbarity Syrians have endured and reported for years,” Pedersen said in a statement. Documentation and testimonies “only scratch the surface of the carceral system’s horrors,” he added. Pedersen urged authorities to cooperate with U.N. bodies like an independent Commission of Inquiry on Syria, which was created in 2011, and an independent group known as the IIIM that was set up five years later to also compile evidence of crimes. ROME — Leaders of the Group of 7 industrialized nations offered their full support for an inclusive political transition in Syria and invited all parties to preserve the country’s territorial integrity. In a message released by Italian Premier Giorgia Meloni’s office, the leaders said they were ready to support a transition that “leads to a credible government, inclusive and not sectarian, that guarantees respect for the state of law, universal human rights, including rights for women, (and) the protection of all Syrians, including religious and ethnic minorities.” The leaders also underlined the importance that ousted President Bashar Assad’s government is held responsible for crimes, citing “decades of atrocities.” They said they would also cooperate with groups working to prohibit chemical weapons “to secure, declare and destroy” remaining chemical arms in Syria. Italy currently holds the rotating presidency of the G-7, which also includes Britain, Canada, France, Germany, Japan and the United States. JERUSALEM — The Israeli military says it struck Hamas militants in two locations in the southern Gaza Strip who planned to hijack aid convoys. Palestinian Health officials had earlier said that the two strikes killed 15 men who were part of local committees established to secure aid deliveries. The committees have been organized in cooperation with the Hamas-run Interior Ministry in Gaza. It was not possible to independently confirm either account of the strikes, which occurred overnight into Thursday. Israel has long accused Hamas of hijacking humanitarian aid deliveries, while U.N. officials have said there is no systemic diversion of aid . U.N. agencies and aid groups say deliveries are held up by Israeli restrictions on the entry of aid and movement within Gaza, as well as the breakdown of law and order more than 14 months into the war between Israel and Hamas. Israel has repeatedly targeted the Hamas-run police force, which maintained internal security before the war. The United Nations agency for Palestinian refugees, the main aid provider in Gaza, said a U.N. convoy of 70 trucks carrying humanitarian aid in southern Gaza “was involved in a serious incident,” resulting in just one of the trucks reaching its destination. It did not provide further details on the incident but said the same route had been used successfully two days earlier. Israel’s offensive, launched after Hamas’ Oct. 7, 2023, attack, has caused vast destruction and displaced around 90% of Gaza’s population of 2.3 million, leaving the territory heavily reliant on international food aid. DAMASCUS, Syria — An American who turned up in Syria on Thursday says he was detained after crossing into the country by foot on a Christian pilgrimage seven months ago. Travis Timmerman appears to have been among thousands of people released from the country’s notorious prisons after rebels reached Damascus over the weekend, overthrowing President Bashar Assad and ending his family’s 54-year rule. As video emerged online of Timmerman on Thursday, he was initially mistaken by some for Austin Tice, an American journalist who went missing in Syria 12 years ago. In the video, Timmerman could be seen lying on a mattress under a blanket in what appeared to be a private house. A group of men in the video said he was being treated well and would be safely returned home. The Biden administration is working to bring Timmerman home, Secretary of State Antony Blinken told reporters in Aqaba, Jordan, without offering details, citing privacy. Timmerman later gave an interview with the Al-Arabiya TV network, saying he had illegally crossed into Syria on foot from the eastern Lebanese town of Zahle seven months ago, before being detained. He said he was treated well in detention but could hear other men being tortured. AQABA, Jordan — U.S. Secretary of State Antony Blinken has arrived in Jordan on his 12th visit to the Mideast since the Israel-Hamas war erupted last year and his first since the weekend ouster of Syrian President Bashar Assad that has sparked new fears of instability in a region wracked by three conflicts despite a ceasefire agreement in Lebanon. Blinken was meeting in Aqaba with Jordan’s King Abdullah II and Foreign Minister Ayman Safadi on Thursday before traveling to Turkey for talks with Turkish officials on Friday. The meetings will focus largely on Syria but also touch on long-elusive hopes for a deal to end the fighting in Gaza that has devastated the Palestinian territory since October 2023. Blinken is the latest senior U.S. official to visit the Middle East in the five days since Assad was deposed as the Biden administration navigates more volatility in the region in its last few weeks in office and as President-elect Donald Trump has said the U.S. should stay out of the Syrian conflict. Other include national security adviser Jake Sullivan and a top military commander who traveled there as the U.S. and Israel have launched airstrikes to prevent the Islamic State militant group from reconstituting and prevent materiel and suspected chemical weapons stocks from falling into militant hands. Blinken “will discuss the need for the transition process and new government in Syria to respect the rights of minorities, facilitate the flow of humanitarian assistance, prevent Syria from being used as a base of terrorism or posing a threat to its neighbors, and ensure that chemical weapons stockpiles are secured and safely destroyed,” the State Department said. The U.S. would be willing to recognize and fully support a new Syrian government that met those criteria. U.S. officials say they are not actively reviewing the foreign terrorist organization designation of the main Syrian rebel group, Hayat Tahrir al-Sham, known as HTS, which was once an al-Qaida affiliate, but stressed they are not barred from speaking to its members. JERUSALEM — Israeli Prime Minister Benjamin Netanyahu says Israeli forces will remain in a Syrian buffer zone until a new force on the other side of the border can guarantee security. After the overthrow of Syrian President Bashar Assad, Israeli forces pushed into a buffer zone that had been established after the 1973 Mideast war. The military says it has seized additional strategic points nearby. Israeli officials have said the move is temporary, but Netanyahu’s conditions could take months or even years to fulfill as Syria charts its post-Assad future, raising the prospect of an open-ended Israeli presence in the country. Netanyahu’s office said in a statement Thursday that Assad’s overthrow by jihadi rebels created a vacuum on the border. “Israel will not permit jihadi groups to fill that vacuum and threaten Israeli communities on the Golan Heights with October 7th style attacks,” it said, referring to Hamas’ 2023 attack out of Gaza, which ignited the war there. “That is why Israeli forces entered the buffer zone and took control of strategic sites near Israel’s border.” The statement added that “this deployment is temporary until a force that is committed to the 1974 agreement can be established and security on our border can be guaranteed.” The buffer zone is adjacent to the Golan Heights, which Israel captured from Syria in the 1967 Mideast war and later annexed. The international community, except for the United States, views the Golan as occupied Syrian territory. JERUSALEM — Israel’s military said Thursday that the attacker who fatally shot a 12-year-old Israeli boy in the occupied West Bank overnight turned himself in to authorities. The attacker opened fire on a bus near the Israeli settlement of Beitar Illit, critically wounding the boy, who hospital authorities pronounced dead in the early morning. Three others were wounded in the attack, paramedics said. The shooting took place just outside Jerusalem in an area near major Israeli settlements. JAKARTA, Indonesia — The Indonesian government has evacuated 37 citizens from Syria following the fall of the Bashar al-Assad government, officials said Thursday. The evacuees were taken by land from Damascus to Beirut, where they boarded three commercial flights to Jakarta, said Judha Nugraha, director of citizen protection at the Foreign Affairs Ministry. The Indonesian Embassy in Damascus said all 1,162 Indonesian citizens in Syria were safe. Indonesian Ambassador to Syria Wajid Fauzi said the situation in Syria has gradually returned to normal. “I can say that 98% of people’s lives are back to normal, shops are open, public transportation has started running,” Fauzi said, adding that most Indonesian nationals living in Syria had chosen to stay. DEIR AL-BALAH, Gaza Strip — Palestinian medical officials say Israeli airstrikes have killed at least 28 people in the Gaza Strip, including seven children and a woman. One of the strikes overnight and into Thursday flattened a house in the built-up Nuseirat refugee camp, according to the Al-Aqsa Martyrs Hospital in the nearby city of Deir al-Balah, where the casualties were taken. An Associated Press reporter saw the bodies at the hospital’s morgue. Two other strikes killed 15 men who were part of local committees established to secure aid convoys . The committees were set up by displaced Palestinians in coordination with the Hamas-run Interior Ministry. The Nasser Hospital in the southern city of Khan Younis received the bodies and an AP reporter counted them. The hospital said eight were killed in a strike near the southern border town of Rafah and seven others in a strike 30 minutes later near Khan Younis. The war in Gaza began when Hamas-led militants attacked southern Israel on Oct. 7, 2023, killing some 1,200 people, mostly civilians, and abducting around 250 people. Some 100 hostages are still inside Gaza, at least a third of whom are believed to be dead. Israel’s offensive has killed over 44,800 Palestinians in Gaza, more than half of them women and children, according to the Gaza Health Ministry, which does not say how many were combatants. The Israeli military says it has killed over 17,000 militants, without providing evidence. The fighting has plunged Gaza into a severe humanitarian crisis, with experts warning of famine. Israel says it allows enough aid to enter and blames U.N. agencies for not distributing it. The U.N. says Israeli restrictions, and the breakdown of law and order after Israel repeatedly targeted the Hamas-run police force, make it extremely difficult to operate in the territory. UNITED NATIONS — The U.N. General Assembly overwhelmingly approved resolutions Wednesday demanding an immediate ceasefire in Gaza and backing the U.N. agency for Palestinian refugees that Israel has moved to ban . The votes in the 193-nation world body were 158-9 with 13 abstentions to demand a ceasefire now and 159-9 with 11 abstentions to support the agency known as UNRWA. The votes culminated two days of speeches overwhelmingly calling for an end to the 14-month war between Israel and the militant Hamas group . General Assembly resolutions are not legally binding, though they reflect world opinion. There are no vetoes in the assembly. Israel and its close ally, the United States, were in a tiny minority speaking and voting against the resolutions.

Stolen ruby slippers worn by Judy Garland in 'The Wizard of Oz' are auctioned for $28 million

100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD negativity in MajesTEC-5 as induction therapy and MajesTEC-4 as maintenance therapy 1 , 2 BEERSE, BELGIUM, Dec. 08, 2024 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company, today announced new frontline data featuring TECVAYLI ® ▼ (teclistamab) from two investigational studies in patients with newly diagnosed multiple myeloma (NDMM) in induction and maintenance settings. 1 , 2 The MajesTEC-5 (Abstract #493) and MajesTEC-4 (Abstract #494) studies establish the potential of teclistamab for use in newly diagnosed patients, with promising efficacy and a tolerable safety profile. 1 , 2 These data were highlighted as oral presentations at the 2024 American Society of Hematology (ASH) Annual Meeting, taking place in San Diego, California, United States from 7-10 December. 1 , 2 Forty-nine patients with transplant-eligible NDMM were treated with teclistamab in combination with DARZALEX ® (daratumumab) subcutaneous (SC) formulation, lenalidomide and dexamethasone (Tec-DRd) or daratumumab SC, bortezomib, lenalidomide and dexamethasone (Tec-DVRd) as induction therapy in the MajesTEC-5 study. 1 All patients who were evaluated for MRD negativity after cycle 3 of induction therapy achieved MRD negativity (10 -5 ) and maintained through cycle 6. 1 "These data from the MajesTEC-5 study build on the growing body of evidence of teclistamab combinations that support the potential combinability of teclistamab with other effective therapies, demonstrating high rates of MRD-negative responses for evaluable patients with newly diagnosed multiple myeloma,” said Rachel Kobos, M.D., Vice President, Oncology Research & Development, Johnson & Johnson Innovative Medicine. "At Johnson & Johnson, our deep expertise and understanding of multiple myeloma has shaped the regimens we're developing, including our bispecific antibodies in new combinations, and we're committed to exploring the full potential of our therapies to improve outcomes for patients.” The safety profiles were manageable and consistent with individual safety profiles. 1 No treatment-emergent adverse events (TEAEs) led to study treatment discontinuation or death; cytokine release syndrome (CRS; Grade 1 or 2) occurred in 65 percent of patients. 1 No patients experienced immune effector cell-associated neurotoxicity syndrome (ICANS). 1 Grade 3/4 TEAEs included lymphopenia (43 percent), neutropenia (57 percent) and infections (35 percent). 1 "There remains opportunity to achieve even deeper and more sustained outcomes for a broader patient population in the frontline setting,” said Marc S. Raab, M.D., Heidelberg University Hospital, Germany.* "These data reinforce the potential of teclistamab when used in earlier lines and show that teclistamab can be leveraged to optimise existing standard regimens in combination.” Results from the safety run-in of the Phase 3 MajesTEC-4 study highlighted the potential of teclistamab to be administered as a maintenance therapy following autologous stem cell transplant (ASCT). 2 MajesTEC-4 is the first study to present data on a B-cell maturation antigen (BCMA) bispecific as monotherapy or combination therapy after ASCT. 2 Low rates of non-haematologic Grade 3/4 TEAEs and discontinuation of treatment due to all TEAEs (5.3 percent) were observed. 2 CRS events were all Grade 1/2, mostly occurring during step-up dosing, and ICANS was not observed. 2 Neutropenia and infections were the most common Grade 3/4 TEAEs. 2 Grade 3/4 neutropenia at 6 months showed a decreased trend in cohorts 2 and 3 with less frequent teclistamab dosing (cohort 1: 94 percent, cohort 2: 63 percent, cohort 3: 47 percent). 2 A similar trend was observed for all-grade infections (cohort 1: 94 percent; cohort 2: 78 percent; cohort 3: 77 percent). 2 All evaluable patients in cohort 1 who underwent MRD assessment after 12 months of therapy were MRD negative, and 100 percent of evaluable patients assessed in cohorts 2 and 3 were also MRD negative at cycle 6. 2 Further analysis of combination therapies will be evaluated in the Phase 3 MajesTEC-7 study which is currently enrolling. 3 "Teclistamab was the first BCMA bispecific therapy approved as monotherapy for relapsed and refractory multiple myeloma and plays an important role in our approach to transform outcomes for all people living with this complex disease,” said Edmond Chan, MBChB, M.D. (Res), EMEA Therapeutic Area Lead Hematology, Johnson & Johnson Innovative Medicine. "The deep MRD negativity results achieved by teclistamab in earlier lines and in combination with established regimens, including daratumumab, reinforce the potential of this transformative therapy as we build on our aim towards no longer treating to progression but treating to cure.” About MajesTEC-5 Study MajesTEC-5 ( NCT05695508 ) is an ongoing, Phase 2 study of teclistamab and talquetamab, evaluating the safety and efficacy of combination regimens in participants with transplant-eligible NDMM. 4 About MajesTEC-4 Study MajesTEC-4 ( NCT05243797 ) is an ongoing, multicentre, randomised, open-label, Phase 3 study of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone in participants with NDMM as maintenance therapy following ASCT. 5 About MajesTEC-7 Study MajesTEC-7 ( NCT05552222 ) is a Phase 3 randomised study comparing teclistamab in combination with daratumumab SC and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab SC and lenalidomide (Tal-DR) versus daratumumab SC, lenalidomide, and dexamethasone (DRd) in participants with NDMM who are either ineligible or not intended for ASCT as initial therapy. 3 About Teclistamab Teclistamab is an off-the-shelf (or ready to use) bispecific antibody. 6 Teclistamab, a subcutaneous injection, redirects T-cells through two cellular targets (BCMA and CD3) to activate the body's immune system to fight the cancer. Teclistamab is currently being evaluated in several combination studies. 6 , 7 , 8 , 9 , 10 Teclistamab received European Commission (EC) approval in August 2022 for the treatment of patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy. 11 In August 2023, the EC approved a Type II variation application for teclistamab, providing the option for a reduced dosing frequency of 1.5mg/kg every two weeks in patients who have achieved a complete response (CR) or better for a minimum of six months. 12 For a full list of adverse events and information on dosage and administration, contraindications and other precautions when using teclistamab, please refer to the Summary of Product Characteristics . In line with European Medicine Agency (EMA) regulations for new medicines and those given conditional approval, teclistamab is subject to additional monitoring. About Daratumumab and Daratumumab SC Johnson & Johnson is committed to exploring the potential of daratumumab for patients with multiple myeloma (MM) across the spectrum of the disease. In August 2012 , Janssen Biotech, Inc., a Johnson & Johnson company and Genmab A/S entered a worldwide agreement, which granted Johnson & Johnson an exclusive licence to develop, manufacture and commercialise daratumumab. Since launch, daratumumab has become a foundational therapy in the treatment of MM, having been used in the treatment of more than 585,000 patients worldwide. 13 Daratumumab is the only CD38-directed antibody approved to be given subcutaneously to treat patients with MM. 14 Daratumumab SC is co-formulated with recombinant human hyaluronidase PH20 (rHuPH20), Halozyme's ENHANZE ® drug delivery technology. 15 CD38 is a surface protein that is present in high numbers on MM cells, regardless of the stage of disease. 16 Daratumumab binds to CD38 and inhibits tumour cell growth causing myeloma cell death. 8 Daratumumab may also have an effect on normal cells. 17 Data across ten Phase 3 clinical trials, in both the frontline and relapsed settings, have shown that daratumumab-based regimens resulted in significant improvement in progression-free survival and/or overall survival. 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 For further information on daratumumab, please see the Summary of Product Characteristics at: https://www.ema.europa.eu/en/documents/product-information/darzalex-epar-product-information_en.pdf . About Multiple Myeloma MM is an incurable blood cancer that affects a type of white blood cell called plasma cells, which are found in the bone marrow. 27 , 28 In MM, these malignant plasma cells change and grow out of control. In the European Union, it is estimated that more than 35,000 people were diagnosed with MM in 2022, and more than 22,700 patients died. 29 While some patients with MM initially have no symptoms, others can have common symptoms of the disease, which can include bone fracture or pain, low red blood cell counts, tiredness, high calcium levels or kidney failure. 30 About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at www.innovativemedicine.jnj.com/emea . Follow us at www.linkedin.com/company/jnj-innovative-medicine-emea . Janssen-Cilag International NV, Janssen Pharmaceutica NV, Janssen-Cilag Limited, Janssen Biotech, Inc., and Janssen Research & Development, LLC are Johnson & Johnson companies. Cautions Concerning Forward-Looking Statements This press release contains "forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding product development and the potential benefits and treatment impact of teclistamab and daratumumab SC. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialise, actual results could vary materially from the expectations and projections of Janssen Pharmaceutica NV, Janssen-Cilag Limited, Janssen Biotech, Inc., Janssen Research & Development, LLC and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behaviour and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements” and "Item 1A. Risk Factors,” and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at http://www.sec.gov/ , http://www.jnj.com/ or on request from Johnson & Johnson. None of Janssen Pharmaceutica NV, Janssen-Cilag Limited, Janssen Biotech, Inc., Janssen Research & Development, LLC nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments. * Marc S. Raab, M.D., has provided consulting, advisory, and speaking services to Johnson & Johnson; he has not been paid for any media work. 2 Zamagni E et al. 494 Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the MajesTEC-4/EMN30 Trial. Oral presentation. American Society of Hematology (ASH) Annual Meeting; December 7-10, 2024. 3 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7). Available at: https://classic.clinicaltrials.gov/ct2/show/NCT05552222 . Last accessed December 2024. 4 GMMG-HD10 /​ DSMM-XX /​ 64007957MMY2003, MajesTEC-5 (HD10/DSMMXX). Available at: https://clinicaltrials.gov/study/NCT05695508 . Last accessed December 2024. 5 Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4). Available at: https://clinicaltrials.gov/study/NCT05243797 . Last accessed December 2024. 6 European Medicines Agency. TECVAYLI Summary of Product Characteristics. Available at: https://www.ema.europa.eu/en/documents/product-information/tecvayli-epar-product-information_en.pdf . Last accessed: December 2024. 7 ClinicalTrials.gov. A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma (MajesTEC-2). Available at: https://clinicaltrials.gov/ct2/show/NCT04722146 . Last accessed: December 2024. 8 ClinicalTrials.gov. A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma. Available at: https://clinicaltrials.gov/ct2/show/NCT04586426 . Last accessed: December 2024. 9 ClinicalTrials.gov. A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma. Available at: https://clinicaltrials.gov/ct2/show/NCT04108195 . Last accessed: December 2024. 10 ClinicalTrials.gov. A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (TecDara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-3). Available at: https://clinicaltrials.gov/ct2/show/NCT05083169 . Last accessed: December 2024. 11 Janssen.com. Janssen Marks First Approval Worldwide. Available at: https://www.janssen.com/emea/sites/www_janssen_com_emea/files/teclistamab_ec_approval_release.pdf . Last accessed: December 2024. 12 Janssen.com. European Commission Approves Reduced Dosing Frequency for Janssen's Bispecific Antibody TECVAYLI®▼ (teclistamab). Available at: https://www.jnj.com/media-center/press-releases/european-commission-approves-reduced-dosing-frequency-for-janssens-bispecific-antibody-tecvayli-teclistamab . Last accessed: December 2024. 13 Data on file. RF-439245. October 2024. 14 Sonneveld P et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med 2024; 390:301-313. 15 Janssen EMEA. European Commission Grants Marketing Authorisation for DARZALEX ® (Daratumumab) Subcutaneous Formulation for All Currently Approved Daratumumab Intravenous Formulation Indications. Available at: www.businesswire.com/news/home/20200604005487/en/European-Commission-GrantsMarketingAuthorisation-for-DARZALEX%C2%AE%E2%96%BC-daratumumab-SubcutaneousFormulation-for-all-CurrentlyApproved-Daratumumab-Intravenous-Formulation-Indications . Last accessed: December 2024. 16 European Medicines Agency. DARZALEX (daratumumab) Summary of Product Characteristics. Available at: https://www.ema.europa.eu/en/documents/product-information/darzalex-epar-product-information_en.pdf . Last accessed: December 2024. 17 Moreau P et al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Lancet 2019;394(10192):29-38. 18 Facon T et al. MAIA Trial Investigators. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. N Engl J Med 2019;380(22):2104-2115. 19 Mateos MV et al. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. The Lancet 2020;395:P132-141. 20 Dimopoulos MA et al. APOLLO Trial Investigators. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial. Lancet Oncol 2021;22(6):801-812. 21 Palladini G et al. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood 2020;2;136(1):71-80. 22 Chari A et al. Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Blood 2017;130(8):974-981. 23 Bahlis NJ et al. Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study. Leukemia 2020;34(7):1875-1884. 24 Mateos MV et al. Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR. Clin Lymphoma Myeloma Leuk 2020;20(8):509-518. 25 Sonneveld P et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med 2024;390(4):301-313. DOI: 10.1056/NEJMoa23120 26 Usmani S Z et al. Daratumumab + Bortezomib/Lenalidomide/Dexamethasone in Patients With Transplant-ineligible or Transplant-deferred Newly Diagnosed Multiple Myeloma: Results of the Phase 3 CEPHEUS Study. Oral presentation. 21 st International Myeloma Society (IMS) Annual Meeting; September 25-28, 2024. 27 American Society of Clinical Oncology. Multiple myeloma: introduction. Available at: https://www.cancer.net/cancer-types/multiple-myeloma/introduction . Last accessed: December 2024. 28 Abdi J et al. Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms. Oncotarget 2013;4(12):2186-2207. 29 European Cancer Information System. Estimates of cancer incidence and mortality in 2022, by country. Multiple myeloma. Available at: https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1,2$3-51$6-0,85$5-2022,2022$7-7$CEstByCountry$X0_8-3$X0_19-AE27$X0_20-No$CEstBySexByCountry$X1_8-3$X1_19-AE27$X1_-1-1$CEstByIndiByCountry$X2_8-3$X2_19-AE27$X2_20-No$CEstRelative$X3_8-3$X3_9-AE27$X3_19-AE27$CEstByCountryTable$X4_19-AE27 . Last accessed: December 2024. 30 American Cancer Society. Multiple myeloma: early detection, diagnosis and staging. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8740.00.pdf . Last accessed: December 2024. CP-492505 December 2025 CONTACT: Media contact: Jenni Mildon [email protected] +44 7920 418 552 Investor contact: Lauren Johnson [email protected]

COPPER MOUNTAIN, Colo. — For a pair of lower-level downhill events, this sure had plenty of Olympic medal-capturing and World Cup-winning ski racers. The stage belonged to Lindsey Vonn, the 40-year-old who took another step on her comeback trail Saturday with her first races in nearly six years. Vonn wasn't particularly speedy and finished in the middle of the pack on a cold but sunny day at Copper Mountain. Times and places weren't the mission, though, as much as getting used to the speed again and gaining the necessary points to compete on the World Cup circuit this season. Vonn accomplished both, finishing 24th in the first downhill race of the day and 27th in the second. She posted on social media after the FIS races that she had enough points to enter World Cup events. The timing couldn't be more perfect — the next stop on the women's circuit is Beaver Creek, Colorado, in a week. Vonn, who used to own a home in nearby Vail, hasn't committed to any sort of timetable for a World Cup return. “Today was a solid start and I had a blast being in start with my teammates again!” Vonn wrote on X. “While I’m sure people will speculate and say I’m not in top form because of the results, I disagree. This was training for me. I’m still testing equipment and getting back in the groove.” Lindsey Vonn reacts after her run at a downhill skiing race at Copper Mountain Ski Resort on Saturday in Copper Mountain, Colo. Her competition — a veritable who's who of high-profile ski racers — applauded her efforts. “I don't expect her to come back and win — just that she comes back and she has fun,” said Federica Brignone of Italy, a former overall World Cup champion and three-time Olympic medalist. “She's having fun, and she’s doing what she loves. That’s the best thing that she could do.” In the first race on a frigid morning, Vonn wound up 1.44 seconds behind the winning time of 1 minute, 5.79 seconds posted by Mirjam Puchner of Austria. In her second race through the course later in the morning, Vonn was 1.53 seconds behind Cornelia Huetter of Austria, who finished in 1:05.99. Huetter is the reigning season-long World Cup downhill champion. “It’s really nice to compare with her again, and nice to have her (racing) again,” Huetter said. “For sure, for the skiing World Cup, we have a lot of more attention. It's generally good for all racers because everyone is looking.” Also in the field were Nadia Delago of Italy, who won a bronze medal in downhill at the 2022 Beijing Olympics, and Puchner, the Olympic silver winner in super-G in Beijing. In addition, there was Marta Bassino of Italy, a winner of the super-G at the 2023 world championships, and two-time Olympic champion Michelle Gisin of Switzerland. “For me, it was really a training, but it was fun to have a World Cup race level right here,” Gisin said. “It was a crazy race.” Vonn remains a popular figure and took the time after each run to sign autographs for young fans along with posing for photos. Lindsey Vonn competes in a downhill skiing race at Copper Mountain Ski Resort on Saturday in Copper Mountain, Colo. When she left the sport, Vonn had 82 World Cup race victories, which stood as the record for a woman and within reach of the all-time Alpine record of 86 held by Swedish standout Ingemar Stenmark. The women’s mark held by Vonn was surpassed in January 2023 by Mikaela Shiffrin, who now has 99 wins — more than any Alpine ski racer in the history of the sport. Shiffrin is currently sidelined after a crash in a giant slalom event in Killington, Vermont, last weekend. Vonn’s last major race was in February 2019, when she finished third in a downhill during the world championships in Sweden. The three-time Olympic medalist left the circuit still near the top of her game. But all the broken arms and legs, concussions and torn knee ligaments took too big a toll and sent her into retirement. She had a partial knee replacement last April and felt good enough to give racing another shot. “It's very impressive to see all the passion that Lindsey still has,” Gisin said. Also racing Saturday was 45-year-old Sarah Schleper, who once competed for the United States but now represents Mexico. Schleper was the next racer behind Vonn and they got a chance to share a moment between a pair of 40-somethings still racing. “I was like, ‘Give me some tips, Lindsey,’” Schleper said. “She’s like, ‘Oh, it’s a highway tuck, the whole thing.’ Then she’s like, ‘It’s just like the good old days.’" Buffalo Bills quarterback Josh Allen, foreground right, dives toward the end zone to score past San Francisco 49ers defensive end Robert Beal Jr. (51) and linebacker Dee Winters during the second half of an NFL football game in Orchard Park, N.Y., Sunday, Dec. 1, 2024. (AP Photo/Adrian Kraus) Houston Rockets guard Jalen Green goes up for a dunk during the second half of an Emirates NBA cup basketball game against the Minnesota Timberwolves, Tuesday, Nov. 26, 2024, in Minneapolis. (AP Photo/Abbie Parr) South Carolina guard Maddy McDaniel (1) drives to the basket against UCLA forward Janiah Barker (0) and center Lauren Betts (51) during the first half of an NCAA college basketball game, Sunday, Nov. 24, 2024, in Los Angeles. (AP Photo/Eric Thayer) LSU punter Peyton Todd (38) kneels in prayer before an NCAA college football game against Oklahoma in Baton Rouge, La., Saturday, Nov. 30, 2024. LSU won 37-17. (AP Photo/Gerald Herbert) Philadelphia Eagles running back Saquon Barkley, left, is hit by Baltimore Ravens cornerback Marlon Humphrey, center, as Eagles wide receiver Parris Campbell (80) looks on during a touchdown run by Barkley in the second half of an NFL football game, Sunday, Dec. 1, 2024, in Baltimore. (AP Photo/Stephanie Scarbrough) Los Angeles Kings left wing Warren Foegele, left, trips San Jose Sharks center Macklin Celebrini, center, during the third period of an NHL hockey game Monday, Nov. 25, 2024, in San Jose, Calif. (AP Photo/Godofredo A. Vásquez) Olympiacos' Francisco Ortega, right, challenges for the ball with FCSB's David Miculescu during the Europa League league phase soccer match between FCSB and Olympiacos at the National Arena stadium, in Bucharest, Romania, Thursday, Nov. 28, 2024. (AP Photo/Andreea Alexandru) Brazil's Botafogo soccer fans react during the Copa Libertadores title match against Atletico Mineiro in Argentina, during a watch party at Nilton Santos Stadium, in Rio de Janeiro, Saturday, Nov. 30, 2024. (AP Photo/Bruna Prado) Jiyai Shin of Korea watches her shot on the 10th hole during the final round of the Australian Open golf championship at the Kingston Heath Golf Club in Melbourne, Australia, Sunday, Dec. 1, 2024. (AP Photo/Asanka Brendon Ratnayake) Mathilde Gremaud of Switzerland competes in the women's Freeski Big Air qualifying round during the FIS Snowboard & Freeski World Cup 2024 at the Shougang Park in Beijing, Friday, Nov. 29, 2024. (AP Photo/Andy Wong) Lara Gut-Behrami, of Switzerland, competes during a women's World Cup giant slalom skiing race, Saturday, Nov. 30, 2024, in Killington, Vt. (AP Photo/Robert F. Bukaty) New York Islanders goaltender Ilya Sorokin cools off during first period of an NHL hockey game against the Boston Bruins, Wednesday, Nov. 27, 2024, in Elmont, N.Y. (AP Photo/Julia Demaree Nikhinson) Brazil's Amanda Gutierres, second right, is congratulated by teammate Yasmin, right, after scoring her team's first goal during a soccer international between Brazil and Australia in Brisbane, Australia, Thursday, Nov. 28, 2024. (AP Photo/Pat Hoelscher) Las Vegas Raiders tight end Brock Bowers (89) tries to leap over Kansas City Chiefs cornerback Joshua Williams (2) during the first half of an NFL football game in Kansas City, Mo., Friday, Nov. 29, 2024. (AP Photo/Ed Zurga) England's Alessia Russo, left, and United States' Naomi Girma challenge for the ball during the International friendly women soccer match between England and United States at Wembley stadium in London, Saturday, Nov. 30, 2024. (AP Photo/Kirsty Wigglesworth) Minnesota Vikings running back Aaron Jones (33) reaches for an incomplete pass ahead of Arizona Cardinals linebacker Mack Wilson Sr. (2) during the second half of an NFL football game Sunday, Dec. 1, 2024, in Minneapolis. (AP Photo/Abbie Parr) Melanie Meillard, center, of Switzerland, competes during the second run in a women's World Cup slalom skiing race, Sunday, Dec. 1, 2024, in Killington, Vt. (AP Photo/Robert F. Bukaty) Get local news delivered to your inbox!Joel Embiid scores 31 in return to the 76ers' starting lineup against the Bulls

Trump offers inauguration invites to foreign leaders through calls and back channels

'I hope it's a complete disaster for them': Former BYU linebacker and father of Sam Leavitt fully backs Sun DevilsDALLAS (AP) — Luka Doncic is returning to the Dallas lineup Monday night against the Portland Trail Blazers after missing the Mavericks’ two previous games with a left heel contusion. Doncic won last season’s scoring title with a career-best 33.9 points per game and is fifth in the NBA this season averaging 28.9, and seventh in assists, averaging 8.2. He had triple-doubles in three of his last four games, including his most recent appearance last Sunday with 45 points, 13 assists and 11 rebounds in a 143-133 win at Golden State. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Louisville extends athletic director Josh Heird for 5 years through June 2030When one cabinet door opens